Suchergebnisse - "Chen, Xiaoguang"

PubPharm (742)

1

Dynamic gut microbiome-metabolome in cationic bovine serum albumin induced experimental immune-complex glomerulonephritis and effect of losartan and mycophenolate mofetil on microbiota modulation

enthalten in: Journal of pharmaceutical analysis | 2024

von Shi, W. | Li, Z. | Wang, W. | +5

2

Enhanced Sb(V) removal of sulfate-rich wastewater by anaerobic granular sludge assisted with Fe/C amendment

enthalten in: The Science of the total environment | 2024

von Li, Q. | Zhu, Y. | Jiang, N. | +7

3

CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cells

enthalten in: Cancer biology & therapy | 2024

von Liu, S. | Chen, X. | Zhang, L. | +1

4

BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF

enthalten in: Europäisches Patentamt | 2024

von XU HENG | CHEN XIAOGUANG | LIN SONGWEN | +4

5

Design, Synthesis, and Bioevaluation of Novel Reversibly Photoswitchable PI3K Inhibitors Based on Phenylazopyridine Derivatives toward Light-Controlled Cancer Treatment

enthalten in: Journal of medicinal chemistry | 2024

von Zhang, Y. | Deng, J. | Tian, H. | +12

6

Re-expression of epigenetically silenced PTPRR by histone acetylation sensitizes RAS-mutant lung adenocarcinoma to SHP2 inhibition

enthalten in: Cellular and molecular life sciences : CMLS | 2024

von Du, T. | Hu, X. | Hou, Z. | +6

7

Re-expression of epigenetically silenced PTPRR by histone acetylation sensitizes RAS-mutant lung adenocarcinoma to SHP2 inhibition

enthalten in: Cellular and molecular life sciences | 2024

von Du, T. | Hu, X. | Hou, Z. | +6

8

Discovery of Natural Ah Receptor Antagonists from Salvia miltiorrhiza Bunge and Synthesis of Analogs for Tumor Immunotherapy

enthalten in: Journal of medicinal chemistry | 2024

von Li, Z. | Li, S. | Xing, Z. | +10

9

AKR1C3 in carcinomas : from multifaceted roles to therapeutic strategies

enthalten in: Frontiers in pharmacology | 2024

von Li, M. | Zhang, L. | Yu, J. | +6

10

Rational design and optimization of novel 4-methyl quinazoline derivatives as PI3K/HDAC dual inhibitors with benzamide as zinc binding moiety for the treatment of acute myeloid leukemia

enthalten in: European journal of medicinal chemistry | 2024

von Zhang, K. | Huang, R. | Ji, M. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[75]